LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.27 | 770.25 | 4853 | 10730 | 0.4523 | 0.6231 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.50 | 770.25 | 5896 | 10991 | 0.5364 | 0.7002 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.50 | 770.25 | 6002 | 10991 | 0.5461 | 0.7081 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.50 | 770.25 | 5012 | 10991 | 0.4560 | 0.6297 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.75 | 770.25 | 6103 | 11262 | 0.5419 | 0.7072 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.75 | 770.25 | 6358 | 11262 | 0.5645 | 0.7253 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.75 | 770.25 | 5091 | 11262 | 0.4520 | 0.6290 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.98 | 770.25 | 6440 | 11518 | 0.5591 | 0.7232 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.98 | 770.25 | 6628 | 11518 | 0.5754 | 0.7359 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.98 | 770.25 | 5286 | 11518 | 0.4589 | 0.6381 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.20 | 770.25 | 6732 | 11766 | 0.5721 | 0.7353 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.20 | 770.25 | 6935 | 11766 | 0.5894 | 0.7485 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.20 | 770.25 | 5367 | 11766 | 0.4561 | 0.6382 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.42 | 770.25 | 6993 | 12031 | 0.5812 | 0.7442 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.42 | 770.25 | 7329 | 12031 | 0.6091 | 0.7650 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 83.42 | 770.25 | 5400 | 12031 | 0.4488 | 0.6341 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.64 | 770.25 | 7181 | 12287 | 0.5844 | 0.7484 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.64 | 770.25 | 7501 | 12287 | 0.6105 | 0.7676 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 85.64 | 770.25 | 5602 | 12287 | 0.4559 | 0.6431 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 770.25 | 7491 | 12543 | 0.5972 | 0.7596 | MN20160304_L02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 770.25 | 7562 | 12543 | 0.6029 | 0.7637 | MN20160304_L02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 87.86 | 770.25 | 5639 | 12543 | 0.4496 | 0.6397 | MN20160304_L02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.21 | 770.25 | 833 | 904 | 0.9208 | 0.4016 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.21 | 770.25 | 845 | 904 | 0.9341 | 0.4907 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.44 | 770.25 | 958 | 1012 | 0.9459 | 0.7374 | MN20160304_L02 | L07 |